Comparison of different antibodies for detection of progesterone receptor in breast cancer

Steroids

Volumn 67, Issue 9, 2002, Pages 799-813

  Press, Michael ^a,b   Spaulding, Betsy ^c   Groshen, Susan ^b   Kaminsky, David ^d   Hagerty, Margaret ^d   Sherman, Lori ^e   Christensen, Kurt ^e   Edwards, Dean P ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c AGILENT TECHNOLOGIES   (United States)

^d EISENHOWER MEDICAL CENTER   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Breast cancer; Immunohistochemistry; Monoclonal antibody; Paraffin tissue sections; Progesterone receptor

Indexed keywords

FORMALDEHYDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A6; MONOCLONAL ANTIBODY HPRA2; MONOCLONAL ANTIBODY HPRA3; MONOCLONAL ANTIBODY HPRA8; MONOCLONAL ANTIBODY JZB 39; MONOCLONAL ANTIBODY KD 68; MONOCLONAL ANTIBODY PGR1294; MONOCLONAL ANTIBODY PGR636; MONOCLONAL ANTIBODY PR 10A9; MONOCLONAL ANTIBODY PR 2C5; MONOCLONAL ANTIBODY PR 4 12; MONOCLONAL ANTIBODY PR 88; PARAFFIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; ESTROGEN RECEPTOR; TUMOR MARKER;

ANTIBODY SPECIFICITY; ARTICLE; BIOCHEMISTRY; BREAST CARCINOMA; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; TUMOR CELL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; COMPARATIVE STUDY; EPITOPE MAPPING; EVALUATION; FEMALE; IMMUNOLOGY; METABOLISM; MOUSE; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; COMPARATIVE STUDY; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; PARAFFIN EMBEDDING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL; ANIMALS; HUMANS;

EID: 0035996633     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(02)00039-9     Document Type: Article

References (69)

1. 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
2. Prognostic value of steroid hormone receptors: Multivariate analysis of systemically untreated patients with node negative primary breast cancer
3. Correlations between estrogen receptor, progesterone receptor and patient characteristics in human breast cancer
4. Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer: A sequential multivariate analysis of 1262 patients
5. Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis
6. Prognostic value of estrogen and progesterone receptors in primary breast cancer
7. Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy
8. The prognostic value of estrogen and progesterone receptors in female breast cancer: A single center study
9. Progesterone receptors as a prognostic factor in stage II breast cancer
10. Endocrine therapy in human breast cancer: A hypothesis
11. Progesterone receptors and human breast cancer
12. The value of estrogen and progesterone receptors in the treatment of breast cancer
13. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer
14. Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast
15. Methods in laboratory investigation: An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin
16. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies
17. Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody: Relation to biochemical assay, disease-free survival, and clinical endocrine response
18. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer
19. Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancer
20. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders
21. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers
22. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer
23. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): Prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC)
24. An immunohistochemical evaluation of progesterone receptor in frozen sections, paraffin sections, and cytologic imprints of breast carcinomas
25. Prognostic and predictive properties of immunohistochemical progesterone receptors in breast cancer
26. Immunocytochemical staining of progesterone receptor in paraffin sections in human breast cancers
27. Immunocytochemical analysis of progesterone receptors in breast cancer
28. Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating
29. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222
30. Immunohistochemical analysis of hormone receptors, tumor vascularity, and proliferative activity in paraffin-embedded sections of breast carcinoma tissues
31. Demonstration of oestrogen and progesterone receptors in freeze-dried, paraffin-embedded sections of breast cancer
32. Antigen retrieval immunohistochemistry: Past, present and future
33. Microwave-based antigenic unmasking: A revolutionary new technique for routine immunohistochemistry
34. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
35. Comparison of antibodies to estrogen and progesterone receptors and the influence of microwave-antigen retrieval
36. Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas: A correlative study of 942 cases
37. Immunohistochemical analysis of breast carcinoma estrogen and progesterone receptors in paraffin-embedded tissue correlation of clones ER1D5 and 1A6 with a cytosol-based hormone receptor assay
38. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections
39. Multispecimen tissue blocks in pathology: An improved technique of preparation
40. Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system
41. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells
42. Immunologic analysis of human breast cancer progesterone receptors. Part 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies
43. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody
44. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor
45. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
46. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B
47. Identification of a group of ser-pro motif hormone-inducible phosphorylation sites in the human progesterone receptor
48. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor
49. Sex-steroid hormone receptors in human medullary thyroid carcinoma
50. Immunohistochemical detection of female sex hormone receptors in meningiomas: Correlation with clinical and histological features
51. Immunohistological determination of oestrogen receptor, progesterone receptor, and intermediate filaments in Leydig cell tumours, Leydig cell hyperplasia, and normal Leydig cells of the human testis
52. Testicular sex cord stromal tumour with granulosa cell differentiation: Detection of steroid hormone receptors as a possible basis for tumour development and therapeutic management
53. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue
54. 3 receptor in breast cancer and relationship to prognosis
55. Immunohistochemical progesterone receptor assay: Measurement by image analysis
56. Quantitation of estrogen and progesterone receptors by immunocytochemical and image analyses
57. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: Prognostic significance
58. Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma
59. Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval
60. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
61. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
62. New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry
63. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors
64. Immunocytochemical detection of progesterone receptor by monoclonal KD68 antibody in operable breast cancer: Correlation with biochemical assay, pathological features and cell proliferative rate
65. Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique
66. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues
67. Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies
68. Monoclonal antibodies to human progesterone receptor: Characterization by biochemical and immunohistochemical techniques